2 Marijuana Stocks To Buy In 2022 For Better Trading
Are marijuana stock investors stuck in their positions? Meaning that the sector has dropped so much with no real upward sustained trading that it’s been tough to see returns. Now there have been some traders who have been able to profit off of quick upticks. Yet this is not a strategy that is able to be capitalized on by all. So what investors want to see is more consistency in upward momentum that can lead to better trading.
Currently, with the sector still in a decline, there are many who are searching for marijuana stocks to buy. When any sector faces some pullback people will take action to buy the dips. This is done for a few reasons the most obvious is being able to afford top marijuana stocks at a lower share price. The other in addition to a lower entry-level is being prepared for a possible spike in trading. Which is the strategy of buying low and selling high.
Right now there is a good amount of speculative selling and buying at certain points. So with the sector showing more selling and holding it has led to more complications in the sector. The selling comes from the fear of what may not happen in the cannabis industry. Specifically, the fight for federal cannabis reform is the big focus. This same idea of fear is what also has led people to buy marijuana stocks based on the speculation of what happens if federal reform does pass.
Marijuana Stocks Investors Wait For Better Trading
Investors at the moment do not have the clearest path due to the uncertainty about what may happen. To which no one wants to see another year of a massive downtrend. Yet even in a down market marijuana stocks are still showing better all-round volatile action. Hopefully, things will soon come together for the cannabis industry. This could have a positive impact on marijuana stocks seeing a strong recovery.
Top Marijuana Stocks To Watch In 2022
Planet 13 Holdings Inc.
Planet 13 Holdings Inc. an integrated cannabis company, engages in the cultivation, production, distribution, and marketing of cannabis and cannabis-infused products for medical and retail cannabis markets in Nevada, the United States. In recent news, the company’s cultivation expansion fueled superstore in-house product growth.
Words From The Company
“We’ve seen incredible consumer support for our brands like TRENDI and HaHa which have risen to among the top selling brands in their respective categories in Nevada. The only thing that has limited Medizin, our popular premium flower brand, from joining them at the top of the leaderboard has been supply constraints. Our lack of supply has historically led to us selling out every harvest, leaving our customers wanting more,” said Larry Scheffler, Co-CEO of Planet 13.
Cresco Labs Inc.
Cresco Labs Inc. together with its subsidiaries cultivates, manufactures, and sells retail and medical cannabis products in the United States. In recent news, the company announced it will bring FloraCal Farms to Illinois. In other news, back on March 23rd, the company released its Q4 and full-year 2021 results.
Fiscal Year 2021 Financial Highlights
Record revenue of $822 million, an increase of 73% year-over-year
Gross profit excluding fair value mark-up for acquired inventory of $430 million, or 52% of revenue, and up 104% year-over-year
Record adjusted EBITDA1 of $194 million, an increase of 219% year-over-year
Ended the year with over $224 million of cash on hand
Fourth Quarter 2021 Financial Highlights
Record fourth quarter revenue of $218 million, up 34% year-over-year
Record fourth quarter adjusted EBITDA1 of $57 million, or 26% of revenue, an increase of 90% year-over-year
Wholesale revenue of $101 million, maintained position as #1 seller of branded cannabis products in U.S. with leading share in the flower, concentrates, and vape categories
Retail revenue increased 10% sequentially, to $117 million, an average of $2.8 million per store
Same-store-sales increased 28% year-over-year, 1% sequentially
Excluding California, revenue grew 6% sequentially
Record cash flow from operations of $38 million